Patient Name : Ms.

SUPRIYA THAKUR Collected : 01/Jul/2021 01:10PM

Age/Gender : 31 Y 5 M 30 D /F Received : 01/Jul/2021 04:43PM
UHID/MR No : APJ1.0011197882 Reported : 01/Jul/2021 05:47PM
Visit ID : DPVIOPV5135 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : VISHAL NAGAR,Pune

DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method

D-DIMER , CITRATE PLASMA 486.20 ng/mL (FEU) <500 ELFA

Comment:
D-dimer reflects the presence of stabilized fibrin and this has made this marker a useful tool in the diagnosis of venous
thromboembolism (VTE). This test is indicated for use in conjunction with a clinical pretest probability assessment model to
exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) disease in outpatients suspected of DVT or PE.
D-dimer is not specific for DVT/PE and elevated levels are also observed in a variety of other conditions where activation of
coagulation and fibrinolysis occurs (for example, surgery, trauma, infection, inflammation, pregnancy, cancer).
Under certain conditions, lower than expected D-dimer results may occur giving rise to false-negatives. Therefore, it is not safe to
use D-dimer for exclusion of DVT/PE in patients with high pre-test probability, long duration of DVT/PE symptoms (more than
one week) or already under anticoagulant treatment.

Page 1 of 4

SIN No:HA02433348
This test has been performed at Apollo Health and Lifestyle Ltd/Reference Regional Lab, Pune
Patient Name : Ms.SUPRIYA THAKUR Collected : 01/Jul/2021 01:10PM
Age/Gender : 31 Y 5 M 30 D /F Received : 01/Jul/2021 01:47PM
UHID/MR No : APJ1.0011197882 Reported : 01/Jul/2021 05:26PM
Visit ID : DPVIOPV5135 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : VISHAL NAGAR,Pune

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

LIVER FUNCTION TEST (LFT) , SERUM

BILIRUBIN, TOTAL 0.60 mg/dL 0.20-1.20 Colorimetric
BILIRUBIN CONJUGATED (DIRECT) 0.20 mg/dL 0.0-0.3 Calculated
BILIRUBIN (INDIRECT) 0.40 mg/dL 0.0-1.1 Dual Wavelength
ALANINE AMINOTRANSFERASE 72 U/L 9-52 UV with P-5-P
(ALT/SGPT)
ASPARTATE AMINOTRANSFERASE 61.0 U/L 14-36 UV with P-5-P
(AST/SGOT)
ALKALINE PHOSPHATASE 71.00 U/L 38-126 p-nitrophenyl
phosphate
PROTEIN, TOTAL 7.70 g/dL 6.3-8.2 Biuret
ALBUMIN 3.80 g/dL 3.5 - 5 Bromocresol Green
GLOBULIN 3.90 g/dL 2.0-3.5 Calculated
A/G RATIO 0.97 0.8-1.2 Calculated

RENAL PROFILE/RENAL FUNCTION TEST (RFT/KFT) , SERUM

CREATININE 0.80 mg/dL 0.5-1.04 Creatinine
amidohydrolase
UREA 18.60 mg/dL 15-36 Urease
BLOOD UREA NITROGEN 8.7 mg/dL 7.0 - 17.0 Calculated
URIC ACID 6.50 mg/dL 2.5-6.2 Uricase
CALCIUM 8.70 mg/dL 8.4 - 10.2 Arsenazo-III
PHOSPHORUS, INORGANIC 3.10 mg/dL 2.5-4.5 PMA Phenol
SODIUM 137.0 mmol/L 135-145 Direct ISE
POTASSIUM 4.1 mmol/L 3.5-5.1 Direct ISE
CHLORIDE 97.0 mmol/L 98 - 107 Direct ISE

Page 2 of 4

SIN No:BI06701082
Patient Name : Ms.SUPRIYA THAKUR Collected : 01/Jul/2021 01:10PM
Age/Gender : 31 Y 5 M 30 D /F Received : 01/Jul/2021 04:43PM
UHID/MR No : APJ1.0011197882 Reported : 01/Jul/2021 06:42PM
Visit ID : DPVIOPV5135 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : VISHAL NAGAR,Pune

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

C-REACTIVE PROTEIN CRP 42.25 mg/L <5 IMMUNO-

(QUANTITATIVE) , SERUM TURBIDIMETRY

Comment:
C-reactive protein (CRP) is one of the most sensitive acute-phase reactants for inflammation. Measuring changes in the
concentration of CRP provides useful diagnostic information about the level of acuity and severity of a disease. Unlike ESR, CRP
levels are not influenced by hematologic conditions such as anemia, polycythemia etc.

Increased levels are consistent with an acute inflammatory process. After onset of an acute phase response, the serum CRP
concentration rises rapidly (within 6-12 hours and peaks at 24-48 hours) and extensively.Concentrations above 100 mg/L are
associated with severe stimuli such as major trauma and severe infection (sepsis).

Page 3 of 4

SIN No:BI06701342
This test has been performed at Apollo Health and Lifestyle Ltd/Reference Regional Lab, Pune
Patient Name : Ms.SUPRIYA THAKUR Collected : 01/Jul/2021 01:10PM
Age/Gender : 31 Y 5 M 30 D /F Received : 01/Jul/2021 04:46PM
UHID/MR No : APJ1.0011197882 Reported : 01/Jul/2021 06:44PM
Visit ID : DPVIOPV5135 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : VISHAL NAGAR,Pune

DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Range Method

INTERLEUKIN-6, IL-6 , SERUM 12.50 pg/mL <6.4 CLIA

Comment:

Interleukin 6 (IL-6) is a multifunctional protein that regulates the immune response, acute phase reactions, and
hematopoiesis.
Elevated IL-6 levels have been reported to be associated with a variety of diseases, including autoimmune diseases such as
arthritis and Castle man’s disease, mesangial proliferative glomerulonephritis, psoriasis, inflammatory bowel disease and
malignancies such as plasmacytomas, myelomas, lymphomas and leukemia’s, and ovarian cancers.
IL-6 results should be interpreted in light of the total clinical presentation of the patient, including: symptoms, clinical history,
data from additional tests, and other appropriate information.
For assays employing antibodies, the possibility exists for interference by heterophile antibodies in the patient sample.
Patients who have been regularly exposed to animals or have received immunotherapy or diagnostic procedures utilizing
immunoglobulins or immunoglobulin fragments may produce antibodies, e.g. HAMA, that interfere with immunoassays. Such
interfering antibodies may cause erroneous results.

*** End Of Report ***

Page 4 of 4

SIN No:IM02664917
This test has been performed at Apollo Health and Lifestyle Ltd/Reference Regional Lab, Pune